trial comparing the efficacy of subcutaneous low dose cytarabine alone or in combination with isotretinoin versus supportive treatment alone. The therapeutic potential of interferons, haemopoietic growth factors, and other biological response modifiers is currently being evaluated. Preliminary results suggest that these may provide a novel strategy for treating myelodysplastic syndromes.
scite is a Brooklyn-based startup that helps researchers better discover and evaluate scientific articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by researchers from dozens of countries and is funded in part by the National Science Foundation and the National Institute of Drug Abuse of the National Institutes of Health.